Cardillo, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 2.672
AS - Asia 2.217
EU - Europa 2.027
SA - Sud America 526
AF - Africa 42
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 3
Totale 7.494
Nazione #
US - Stati Uniti d'America 2.597
SG - Singapore 995
CN - Cina 523
BR - Brasile 426
DE - Germania 414
PL - Polonia 314
IT - Italia 269
SE - Svezia 237
VN - Vietnam 225
UA - Ucraina 187
FR - Francia 153
IE - Irlanda 101
IN - India 98
FI - Finlandia 91
RU - Federazione Russa 85
GB - Regno Unito 73
ID - Indonesia 72
AR - Argentina 46
HK - Hong Kong 45
JP - Giappone 43
TR - Turchia 39
MX - Messico 33
BD - Bangladesh 32
IQ - Iraq 32
BE - Belgio 28
CA - Canada 22
KR - Corea 21
NL - Olanda 19
IR - Iran 18
ZA - Sudafrica 16
UZ - Uzbekistan 15
AT - Austria 14
CO - Colombia 14
ES - Italia 14
EC - Ecuador 13
PK - Pakistan 8
PY - Paraguay 8
CH - Svizzera 7
CL - Cile 7
CZ - Repubblica Ceca 7
EG - Egitto 7
AU - Australia 6
JO - Giordania 6
KE - Kenya 6
MY - Malesia 6
SA - Arabia Saudita 6
VE - Venezuela 6
CR - Costa Rica 5
DK - Danimarca 5
PH - Filippine 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
HN - Honduras 4
KZ - Kazakistan 4
OM - Oman 4
IL - Israele 3
JM - Giamaica 3
MA - Marocco 3
NP - Nepal 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BO - Bolivia 2
CI - Costa d'Avorio 2
ET - Etiopia 2
GT - Guatemala 2
LT - Lituania 2
LY - Libia 2
NI - Nicaragua 2
TH - Thailandia 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
HR - Croazia 1
HT - Haiti 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
SR - Suriname 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.494
Città #
Singapore 545
Ashburn 334
Warsaw 309
Chandler 291
San Jose 283
Beijing 106
Dublin 94
Ho Chi Minh City 85
Fairfield 79
San Mateo 79
Jacksonville 77
Ann Arbor 74
Wilmington 71
Houston 69
New York 67
Woodbridge 65
Hefei 62
Lauterbourg 62
Munich 62
Rome 60
Jakarta 59
Los Angeles 51
Seattle 48
Milan 46
Nanjing 45
Hanoi 44
Boston 43
Cattolica 41
Hong Kong 40
São Paulo 40
Helsinki 38
The Dalles 38
Tokyo 38
Dallas 33
Lawrence 33
Moscow 33
Marseille 30
Saint Petersburg 30
Dearborn 28
Nanchang 28
Council Bluffs 25
Cambridge 24
Brussels 21
Kent 20
Redwood City 20
Frankfurt am Main 19
Orem 19
Princeton 18
Chicago 17
Bremen 16
Seoul 16
Tianjin 16
Brasília 15
Mountain View 15
Tashkent 15
Haiphong 13
Turku 13
Buffalo 12
Izmir 12
London 12
Santa Clara 12
Paris 11
Baghdad 10
Da Nang 10
Guangzhou 10
Lancaster 10
Mexico City 10
Rio de Janeiro 10
Boardman 9
Chennai 9
Norwalk 9
Nuremberg 9
University Park 9
Bursa 8
Changsha 8
Curitiba 8
Hangzhou 8
Hebei 8
Jiaxing 8
Ninh Bình 8
Nürnberg 8
Pune 8
Shanghai 8
Shenyang 8
Vienna 8
Belo Horizonte 7
Brooklyn 7
Busto Arsizio 7
Istanbul 7
Johannesburg 7
St Louis 7
Toronto 7
Washington 7
Amman 6
Buenos Aires 6
Campinas 6
Denver 6
Dhaka 6
Fremont 6
Hải Dương 6
Totale 4.320
Nome #
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 356
Human obesity and endothelium-dependent responsiveness 341
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 197
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 193
Effects of GLP-1 on Forearm Vasodilator Function and Glucose Disposal During Hyperinsulinemia in the Metabolic Syndrome 188
Mesothelioma in Familial Mediterranean Fever With Colchicine Intolerance: A Case Report and Literature Review 182
Vascular Effects of Obestatin in Lean and Obese Subjects 176
Selective cardiac neuroadrenergic abnormalities in hypertensive patients with left ventricular hypertrophy 161
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 156
Beneficial Effects of Apelin on Vascular Function in Patients with Central Obesity 140
Tumor necrosis factor-alpha antagonism improves vasodilation during hyperinsulinemia in metabolic syndrome 139
Improved Endothelial Function After Endothelin Receptor Blockade in Patients With Systemic Sclerosis 137
Ghrelin Restores the Endothelin 1/Nitric Oxide Balance in Patients With Obesity-Related Metabolic Syndrome 136
Leptin stimulates both endothelin-1 and nitric oxide activity in lean subjects but not in patients with obesity-related metabolic syndrome 125
Coexistence of functional angiotensin II type 2 receptors mediating both vasoconstriction and vasodilation in humans 122
Favorable Vascular Actions of Angiotensin-(1-7) in Human Obesity 122
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome. 120
Tumor necrosis factor-alpha antagonism improves endothelial dysfunction in patients with Crohn's disease 118
CD26: a multi-purpose pharmacological target 118
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 114
Obesity and kidney disease: Beyond the hyperfiltration 112
Variable changes of circulating angptl3 and angptl4 in different obese phenotypes: Relationship with vasodilator dysfunction 112
Endothelial and perivascular adipose tissue abnormalities in obesity-related vascular dysfunction: novel targets for treatment 110
Vasodilator responses and endothelin-dependent vasoconstriction in metabolically healthy obesity and the metabolic syndrome 110
Ghrelin restores the endothelin 1/nitric oxide balance in patients with obesity-related metabolic syndrome. 107
Rho Kinase Inhibition Improves Forearm Vasodilator Responsiveness During Hyperinsulinemia in the Metabolic Syndrome. 106
Mechanisms of SGLT2 (Sodium-Glucose Transporter Type 2) Inhibition-Induced Relaxation in Arteries From Human Visceral Adipose Tissue 105
Increased fractalkine and vascular dysfunction in obesity and in type 2 diabetes. Effects of oral antidiabetic treatment 102
Insulinemia and the risk of breast cancer and its relapse 101
Oxidative stress in diabetes: implications for vascular and other complications 101
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 100
PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia 98
Arterial ageing: from endothelial dysfunction to vascular calcification 98
Calcification biomarkers and vascular dysfunction in obesity and type 2 diabetes: influence of oral hypoglycemic agents. 98
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 96
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 96
Gut hormones and endothelial dysfunction in patients with obesity and diabetes 96
Vasodilator Dysfunction in Human Obesity: Established and Emerging Mechanisms 96
Deterioration of glucose homeostasis in type 2 diabetic patients one year after beginning of statins therapy 95
Intricacies of the endothelin system in human obesity: Role in the development of complications and potential as a therapeutic target 95
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 93
The vascular endothelin system in obesity and type 2 diabetes: Pathophysiology and therapeutic implications 93
Variable dysregulation of circulating lipocalin-2 in different obese phenotypes: Association with vasodilator dysfunction 92
Obesity, blood vessels and metabolic syndrome 90
Generalized impairment of vasodilator reactivity during hyperinsulinemia in patients with obesity-related metabolic syndrome 89
Metabolic profiling of visceral adipose tissue from obese subjects with or without metabolic syndrome. 86
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 85
Vascular hyperpolarization in human physiology and cardiovascular risk conditions and disease 84
Lp-PLA 2 , a new biomarker of vascular disorders in metabolic diseases 84
Emerging pharmacological approaches for the treatment of arterial hypertension 81
Association of Gut Hormones and Microbiota with Vascular Dysfunction in Obesity 77
Increased endothelin-1-mediated vasoconstrictor tone in human obesity: effects of gut hormones 77
Post-surgical spontaneous paroxysmal hypothermia: a case series 76
Toll-like receptor 4 mediates endothelial cell activation through NF-κB but is not associated with endothelial dysfunction in patients with rheumatoid arthritis 76
Exercise is medicine: key to cardiovascular disease and diabetes prevention 76
Mirabegron relaxes arteries from human visceral adipose tissue through antagonism of α1-adrenergic receptors 75
Drug treatments to restore vascular function and diabesity 73
Sex-specific effects of cardiovascular risk factors on endothelium-dependent dilation and endothelin activity in middle-aged women and men. 73
Anti-Inflammatory and Proliferative Properties of Luteolin-7-O-Glucoside 71
10th Anniversary of Biomedicines - Advances in Endothelial Dysfunction 71
Anti-inflammatory and proliferative properties of luteolin-7-O-glucoside 68
Free-amino acid metabolic profiling of visceral adipose tissue from obese subjects 66
Role of vitamin D in obesity 62
Obesity-related changes in the vascular actions of insulin 62
Osteoprotegerin and outcomes in acute coronary syndromes--when the culprit is not the plaque 62
Role of L-type Ca2+-channels in the vasorelaxing response to finerenone in arteries of human visceral adipose tissue 54
Lp-PLA2, a new biomarker of vascular disorders in metabolic diseases 51
The Role of Perivascular Adipose Tissue in the Pathogenesis of Endothelial Dysfunction in Cardiovascular Diseases and Type 2 Diabetes Mellitus 50
Is endothelin targeting finally ready for prime time? 49
Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: A narrative review 47
Chemerin Is the Adipokine Linked with Endothelin-Dependent Vasoconstriction in Human Obesity 40
Totale 7.608
Categoria #
all - tutte 30.867
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 30.867


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202171 0 0 0 0 0 0 0 0 0 18 43 10
2021/2022388 33 32 8 17 32 13 5 69 20 29 63 67
2022/2023859 106 110 72 116 50 116 38 72 114 27 27 11
2023/2024485 21 133 14 17 23 82 40 30 7 19 31 68
2024/20251.039 21 19 76 36 64 33 29 56 134 103 225 243
2025/20262.914 457 112 228 381 501 174 499 124 212 226 0 0
Totale 7.608